If you weren&#8217;t in Austin for the SXSW conference, here&#8217;s video of 23andMe&#8217;s CEO and Cofounder <a href="https://blog.23andme.com/tag/anne-wojcicki">Anne Wojcicki&#8217;</a>s keynote speech on the future of genetics.
Anne talks about how 23andMe created a way for consumers to partner in important genetic research.
<iframe loading="lazy" src="//www.youtube.com/embed/Nr2CHwNyvNI" width="560" height="315" frameborder="0" allowfullscreen="allowfullscreen"></iframe>

A photo portrait of Anne Wojcicki, 23andMe's CEO and co-founder

23andMe Blog

23andMe Blog Team

23andMe’s Anne Wojcicki On The Future of Genetics

At her<a href="http://schedule.sxsw.com/2014/events/event_IAP995218"> South-by-Southwest Interactive</a> keynote, 23andMe CEO and co-founder Anne Wojcicki explained that genetic information will soon be part of our everyday lives.
<img loading="lazy" decoding="async" class="alignright size-medium wp-image-20429" alt="Anne@sxsw" src="https://blog-api.23andme.com/wp-content/uploads/2014/03/Anne@sxsw-231x300.jpg" width="231" height="300" />
“Genetic information is reaching a critical mass,” Anne said.
<h6>Managing Your Health</h6>
As costs drop and as our understanding of genetics improves, the information locked in the genome will be a critical part of managing health for people. But how that information is accessed and interpreted is still being debated. Anne discussed the potential that this information has for people and for research.
Her talk<a href="http://schedule.sxsw.com/2014/events/event_IAP995218"> “The Future of Genetics in Our Everyday Lives”</a> was packed. One person on Twitter said it wasn’t just the longest line she’d seen in ten years at SXSW but the “longest line I’ve seen period.”
<h6>Prevention</h6>
During her talk and a question and answer session that followed and was moderated by journalist Kara Swisher, Anne reiterated the company’s core principles. She co-founded the company, in part, because she wanted to transform health care. Anne said she wanted to turn the industry’s paradigm on its head by creating a business built on preventing disease instead of one that profits from it. 
<iframe loading="lazy" width="560" height="315" src="//www.youtube.com/embed/6A4wtpHZCQI" allowfullscreen="allowfullscreen" frameborder="0"></iframe>
“Genetic information is the basis for personalized medicine and it&#8217;ll help us make better decisions,&#8221; she said.
<h6>Research</h6>
23andMe allows people to contribute to research while learning about themselves. By attracting a large number of customers, the data from those participating in research is helping to accelerate the pace of discovery and give us more insight into disease.
In addition, by allowing people to join others and participate in research, 23andMe has the power to accelerate discoveries in the understanding of different diseases. The company is able to learn more about the genetic basis for disease, why some people are more likely to develop a disease than others and why some therapies work better on some people and not others.
With more than half a million people participating in research, the company has been able to do studies in a few months or years that would have taken others using traditional methods several decades.
<div id="attachment_20768" style="width: 650px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-20768" src="https://blog-api.23andme.com/wp-content/uploads/2014/03/Future-of-Genetic-Infographic-copy1-640x360.jpg" alt="Here's an ImageThink artist's summary of Anne's talk." class="size-large wp-image-20768" width="640" height="360" />Here&#8217;s an ImageThink artist&#8217;s summary of Anne&#8217;s talk.</div>

The Future of Genetics in People’s Lives

On Sunday you can listen in to 23andMe’s CEO and co-founder Anne Wojcicki as she delivers the keynote of the South-by-Southwest Interactive conference in Austin.<img loading="lazy" decoding="async" class="alignright size-full wp-image-17010" alt="23andMe-Anne-001" src="https://blog-api.23andme.com/wp-content/uploads/2012/12/23andMe-Anne-001.jpg" width="165" height="236" />
Her talk <a href="http://schedule.sxsw.com/2014/events/event_IAP995218">“The Future of Genetics in Our Everyday Lives”</a> will be streamed live <a href="http://www.sxsw.com/live" target="_blank" rel="noopener noreferrer">here</a>   at 2 p.m. Central Time or noon Pacific Time. Anne’s talk will include a discussion with the audience and she’ll be taking questions from Twitter using using #AskAnne.
This promises to be a lively discussion not just about 23andMe, but genetics, big data, research and healthcare. If you can’t tune in live, we’ll be updating this post with more details about her presentation after the event. Stay tuned.

23andMe Live From Austin

In a flurry of appearances over the course of a few days earlier this month, 23andMe’s CEO Anne Wojcicki articulated again the role personal genetics will play in health care, and what it might mean to have not just a million people genotyped, but millions.<img loading="lazy" decoding="async" class="alignright wp-image-19715 size-medium" src="http://35.88.189.111/wp-content/uploads/2013/11/Most-Daring-CEO-300x175.jpg" alt="" width="300" height="175" srcset="https://blogcms.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO-300x175.jpg 300w, https://blogcms.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO-768x447.jpg 768w, https://blogcms.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO-1024x597.jpg 1024w, https://blogcms.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO-880x513.jpg 880w, https://blogcms.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO-1180x687.jpg 1180w, https://blogcms.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO.jpg 1629w" sizes="auto, (max-width: 300px) 100vw, 300px" />
“A million people walking around with their genomes, I believe, is going to be disruptive to the health care system,” she said on <a href="https://blog.23andme.com/news/23andmes-daring-ceo-on-cbs/">CBS This Morning last Thursday</a>.
That disruption is a good thing, she said. By giving people access to their genetic information and insight into their own health, individuals – with the advice of their their doctors – can take more informed measures in keeping themselves healthy. That’s a change to a system that traditionally waits until someone is sick to take action, Anne said.
On the Fox Business program The Willis Report, Anne – along with Emily Drabant Conley, PhD, 23andMe’s business development manager – explained how offering people access to their personal genetic information will help give them “a roadmap” for better health. This can  alert individuals to their risks for disease and focus them and their physicians on the best plan for prevention.
Anne talked about this again on <a href="http://video.cnbc.com/gallery/?video=3000215804">CNBC’s On The Money with Maria Bartiromo</a>, where the host said the $99 test, “makes health and access to the data much more democratic.”
A day before her appearance on CBS, Anne said something similar at the<a href="https://www.fastcompany.com/3021310/most-creative-people/fixing-healthcaregov-is-the-least-of-it-when-it-comes-to-fixing-health-"> Innovation Uncensored conference</a>, hosted by Fast Company.
Empowering patients with their 23andMe results can help individuals prevent disease by alerting them to a risk beforehand. And, she said, health care reform – with its emphasis on controlling costs and prevention – will also push this change.
&#8220;Healthcare reform will mean we&#8217;re all more invested in keeping people healthy,&#8221; she said.
Beyond that, 23andMe’s   model also has the power to transform research. By leveraging the power of the Internet, 23andMe’s model enlists individuals in the research process. It offers people a chance to participate, and help in research they believe is important, while also giving them something in return – access to their own results.  This has sped up the research, and helped create communities focused on certain diseases. The data 23andMe gathers is also a resource for researchers, or as <a href="http://dealbook.nytimes.com/2013/11/11/for-99-eliminating-the-mystery-of-pandoras-genetic-box/?_r=1">she said to The New York Times</a>:
“We’re creating a resource for humanity and we don’t want to be the only ones who are getting access to it. As many people as possible should get access to that data,” she said.
Having a million people genotyped, or millions of people, also offers a huge opportunity to gain more insight into not just the genetics behind disease, but the genetics of good health.
&#8220;There&#8217;s a power in having big data,” she said.

23andMe In The News

Late last month, Goldman Sachs hosted their second annual Builders + Innovators Summit bringing together some of the most dynamic entrepreneurs of the day to discuss what they’ve learned to make their companies successful.
As part of that conference, Goldman named 23andMe’s CEO Anne Wojcicki as one of its 100 Most Intriguing Entrepreneurs. Those business leaders on the list were also featured in videos in which they share their insights and stories.
Check out Anne’s video below and take a look at <a href="http://www.goldmansachs.com/our-thinking/our-conferences/builders-and-innovators-2013/index.html">the other entrepreneurs who were named to the list</a>.
<iframe loading="lazy" src="//www.youtube.com/embed/KIMzFWsB5v4" width="560" height="315" frameborder="0" allowfullscreen="allowfullscreen"></iframe>

Builders + Innovators

If you haven’t seen it already, tune into CBS This Morning’s interview with 23andMe’s CEO and co-founder Anne Wojcicki.<img loading="lazy" decoding="async" class="alignright size-medium wp-image-19715" alt="Most Daring CEO" src="https://blog-api.23andme.com/wp-content/uploads/2013/11/Most-Daring-CEO-300x174.jpg" width="300" height="174" />
Sitting down with hosts Charlie Rose, Norah O’Donnell and Gayle King, Anne spoke about how taking the test changed her own life and her goals for 23andMe.
Testing can offer people “a roadmap” for what they could do to potentially stay healthy. As more people test and with enough data, Anne said there is potential to change health care. Her goal is to for people to be empowered with information about their health so that they can be “healthy at 100.”   The goal of having all that information is to better predict health outcomes for people and personalize medicine.
&#8220;A million people walking around with their genomes, I believe, is going to be disruptive to the health care system,&#8221; she said.
Check out “the most daring CEO in America” in action.
<object width="425" height="279" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0"><param name="src" value="http://cnettv.cnet.com/av/video/cbsnews/atlantis2/cbsnews_player_embed.swf" /><param name="scale" value="noscale" /><param name="salign" value="lt" /><param name="background" value="#333333" /><param name="allowfullscreen" value="true" /><param name="allowscriptaccess" value="always" /><param name="flashvars" value="si=254&#038;&#038;contentValue=50158677&#038;shareUrl=https://www.cbsnews.com/video/watch/?id=50158677n" /><embed width="425" height="279" type="application/x-shockwave-flash" src="http://cnettv.cnet.com/av/video/cbsnews/atlantis2/cbsnews_player_embed.swf" scale="noscale" salign="lt" background="#333333" allowfullscreen="allowfullscreen" allowscriptaccess="always" flashvars="si=254&#038;&#038;contentValue=50158677&#038;shareUrl=https://www.cbsnews.com/video/watch/?id=50158677n" /></object>

23andMe’s Daring CEO On CBS

Today in San Francisco,<img loading="lazy" decoding="async" class="alignright size-medium wp-image-19537" alt="Anne Cover Shot" src="https://blog-api.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-282x300.jpg" width="282" height="300" srcset="https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-282x300.jpg 282w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-768x817.jpg 768w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-963x1024.jpg 963w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-827x880.jpg 827w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-1109x1180.jpg 1109w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot.jpg 1648w" sizes="auto, (max-width: 282px) 100vw, 282px" />
Of course 23andMe is there. Our very own co-founder and CEO Anne Wojcicki, recently named by the magazine as the<a href="https://www.fastcompany.com/3018598/for-99-this-ceo-can-tell-you-what-might-kill-you-inside-23andme-founder-anne-wojcickis-dna-r"> “Most Daring CEO In America,”</a> will talk about her vision for the company. &nbsp; 23andMe was founded in part to empower people by giving them access to their own genetic information and involving them in their own health in ways that will also accelerating research and lead to a new era of personalized medicine. Along with talking about 23andMe&#8217;s core values, Anne will explain the benefits of getting tested.
With a welcome from San Francisco Mayor Ed Lee, the conference will include such luminaries as Ben Silbermann, the CEO of Pinterest and Instagram co-founder Mike Krieger and a long list of others.
23andMe will be tweeting out of the meeting most of the day today. You can find us<a href="https://twitter.com/23andMe"> here</a>. Check it out.

23andMe And Innovation

You don’t need an excuse to read the always-interesting magazine<a href="https://www.fastcompany.com/"> Fast Company</a>, but if you did, here it is:
This week’s cover story,  “The Most Daring CEO in America,” features 23andMe’s CEO and co-founder Anne Wojcicki.<img loading="lazy" decoding="async" class="alignright size-medium wp-image-19537" src="https://blog-api.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-282x300.jpg" alt="Anne Cover Shot" width="282" height="300" srcset="https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-282x300.jpg 282w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-768x817.jpg 768w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-963x1024.jpg 963w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-827x880.jpg 827w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot-1109x1180.jpg 1109w, https://blogcms.23andme.com/wp-content/uploads/2013/10/Anne-Cover-Shot.jpg 1648w" sizes="auto, (max-width: 282px) 100vw, 282px" />
Writer Elizabeth Murphy gets to the core of what 23andMe is trying to accomplish: what we’re doing is new, our service offers incredible potential to change how people approach their health and wellness, and that our research model offers new opportunities for scientific discoveries.
But to get there, 23andMe also has to clear some hurdles outlined in Murphy’s story. One of those is simply a matter of explaining the complicated science behind genetics. Another is reaching the people we’ve identified as <a href="https://www.fastcompany.com/3019323/to-know-you-is-to-really-know-you" target="_blank" rel="noopener noreferrer">our core audience</a>: those who see value in having access to their genetic information because of the power that knowledge brings them in managing their own health.
Or as Neil Rothstein, 23andMe’s vice president of marketing, says in the piece, “We’re not really focused on a specific age group or gender or fitness level. It’s people who have this control mind-set.”
Murphy mentions 23andMe’s first-ever<a href="https://www.fastcompany.com/3018619/getting-the-message-out"> TV ad campaign</a>, which also happens to be the first time any personal genetics company has aired this kind of health-focused commercial on television.
While 23andMe is focused on providing valuable health and ancestry information to consumers, 23andMe President Andy Page emphasized that as our customer base grows it will power the research to make important genetic discoveries in the future.
As Anne says in the article 23andMe’s mission as a company isn’t just about return on investment, but “revolutionizing healthcare.”
Check it out here.

A Look At 23andMe’s DNA Revolution

<img loading="lazy" decoding="async" class="alignright size-medium wp-image-18433" alt="23andMe Portraits" src="https://blog-api.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011-210x300.jpg" width="210" height="300" srcset="https://blogcms.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011-210x300.jpg 210w, https://blogcms.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011-768x1097.jpg 768w, https://blogcms.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011-717x1024.jpg 717w, https://blogcms.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011-616x880.jpg 616w, https://blogcms.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011-826x1180.jpg 826w, https://blogcms.23andme.com/wp-content/uploads/2013/06/23andMe-Andy-0011.jpg 1434w" sizes="auto, (max-width: 210px) 100vw, 210px" />Earlier this week 23andMe<a href="https://mediacenter.23andme.com/?p=1182"> appointed</a> Andy Page as company president.
Andy brings to the job incredible business experience as well as a long history with 23andMe. He has watched the company closely since its founding and he has served on the board of directors since 2012. &nbsp;During that time Andy has seen 23andMe grow and articulate its business model. He is both very familiar with what 23andMe does and what it needs to do to continue to be a leader &nbsp;in the personal genomics sector.
He also jumps on board just as 23andMe has hit a period of rapid growth. As president of 23andMe Andy will oversee not just our business strategy, but also our operations. He will report to CEO and Co-Founder Anne Wojcicki, who will lead 23andMe’s research organization and continue to shape the long-term vision of the company.
After talking to employees earlier this week, Anne put Andy’s new position into perspective in a press release.
“Today’s announcement broadens the management team and reflects both our extraordinary growth and future ambitions,” Anne said this week. “Several months ago, we announced a goal of attracting one million customers by the end of 2013. I believe this goal is a stepping-stone for empowering even more individuals to take greater control of their health through personal genetics. Looking to 2014 and beyond, I see the need to focus on this vision for the future as well as our business strategy to ensure the company scales effectively.”
For his part, Andy sees a lot of potential for the business.
“This company can be transformative on a global scale, making personalized medicine and real-time research a reality,” Andy said. “The company has made significant progress in achieving its potential, and working with Anne and the rest of the 23andMe team I look forward to building a successful company that improves health care and &nbsp; advances the understanding of the human genome.”
Check out our press release<a href="https://mediacenter.23andme.com/?p=1182"> here</a> for more about Andy.

Anne Wojcicki — Page 4